Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis

被引:9
|
作者
Elmer, Evelina [1 ]
Smargianaki, Sofia [1 ]
Pettersson, Asa [2 ]
Skattum, Lillemor [3 ,4 ]
Ohlsson, Sophie [2 ]
Hellmark, Thomas [2 ]
Johansson, Asa C. M. [5 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Lab Med Haematol & Transfus Med & Clin Immun, Lund, Region Skane, Sweden
[2] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Nephrol, Lund, Sweden
[3] Lund Univ, Clin Immunol & Transfus Med, Reg Skane, Lund, Sweden
[4] Lund Univ, Dept Lab Med Microbiol Immunol & Glycobiol, Lund, Sweden
[5] Lund Univ, Skane Univ Hosp, Dept Lab Med Haematol & Transfus Med & Clin Genet, Reg Skane, Lund, Sweden
关键词
FOLLOW-UP; RITUXIMAB; ACTIVATION; CYCLOPHOSPHAMIDE; PATHOGENESIS; HOMEOSTASIS; BIOMARKER;
D O I
10.1155/2020/8209737
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cells are thought to play a central role in the pathogenesis of antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV). ANCAs have been proposed to cause vasculitis by activating primed neutrophils to damage small blood vessels. We studied a cohort of AAV patients of which a majority were in remission and diagnosed with granulomatosis with polyangiitis (GPA). Using flow cytometry, the frequencies of CD19(+) B cells and subsets in peripheral blood from 106 patients with AAV and 134 healthy controls were assessed. B cells were divided into naive, preswitch memory, switched memory, and exhausted memory cells. Naive and switched memory cells were further subdivided into transitional cells and plasmablasts, respectively. In addition, serum concentrations of immunoglobulin A, G, and M were measured and clinical data were retrieved. AAV patients displayed, in relation to healthy controls, a decreased frequency of B cells of lymphocytes (5.1% vs. 8.3%) and total B cell number. For the subsets, a decrease in percentage of transitional B cells (0.7% vs. 4.4%) and expansions of switched memory B cells (22.3% vs. 16.5%) and plasmablasts (0.9% vs. 0.3%) were seen. A higher proportion of B cells was activated (CD95(+)) in patients (20.6% vs. 10.3%), and immunoglobulin levels were largely unaltered. No differences in B cell frequencies between patients in active disease and remission were observed. Patients in remission with a tendency to relapse had, compared to nonrelapsing patients, decreased frequencies of B cells (3.5% vs. 6.5%) and transitional B cells (0.1% vs. 1.1%) and an increased frequency of activated exhausted memory B cells (30.8% vs. 22.3%). AAV patients exhibit specific changes in frequencies of CD19(+) B cells and their subsets in peripheral blood. These alterations could contribute to the autoantibody-driven inflammatory process in AAV.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Kubo, Satoshi
    Ishikawa, Yuichi
    Yoshikawa, Maiko
    Sakata, Kei
    Iwata, Shigeru
    Miyagawa, Ippei
    Nakano, Kazuhisa
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [42] Generation of polyclonal plasmablasts from peripheral blood B cells:: a normal counterpart of malignant plasmablasts
    Tarte, K
    De Vos, J
    Thykjaer, T
    Zhan, FH
    Fiol, G
    Costes, V
    Rème, T
    Legouffe, E
    Rossi, JF
    Shaughnessy, J
    Orntoft, TF
    Klein, B
    BLOOD, 2002, 100 (04) : 1113 - 1122
  • [43] CHRONIC DAMAGE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: DATA FROM A NATIONAL REGISTRY
    Hruskova, Zdenka
    Jancova, Eva
    Svojanovsky, Jan
    Kratka, Karolina
    Klaboch, Jan
    Hanzal, Vladimir
    Zamboch, Kamil
    Lanska, Vera
    Jilek, Dalibor
    Tesar, Vladimir
    RHEUMATOLOGY, 2017, 56 : 21 - 21
  • [44] Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
    Yusuke Miyazaki
    Shingo Nakayamada
    Satoshi Kubo
    Yuichi Ishikawa
    Maiko Yoshikawa
    Kei Sakata
    Shigeru Iwata
    Ippei Miyagawa
    Kazuhisa Nakano
    Yoshiya Tanaka
    Arthritis Research & Therapy, 22
  • [45] Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease Activity
    Zabinska, Marcelina
    Koscielska-Kasprzak, Katarzyna
    Krajewska, Joanna
    Bartoszek, Dorota
    Augustyniak-Bartosik, Hanna
    Krajewska, Magdalena
    CELLS, 2021, 10 (07)
  • [46] B CELL DEPLETION AFFECTS CD8 T CELLS IN ANCA-ASSOCIATED VASCULITIS
    Neel, A.
    Bucchia, M.
    Neel, M.
    Rimbert, M.
    Agard, C.
    Hourmant, M.
    Tilly, G.
    Yap, M.
    Perrin, F.
    Graveleau, J.
    Godmer, P.
    Brouard, S.
    Bressollette, C.
    Fakhouri, F.
    Hamidou, M.
    Degauque, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 778 - 778
  • [47] IL-10 producing regulatory B-cells are diminished in ANCA-associated vasculitis
    Wilde, B.
    Thewissen, M.
    Van Paassen, P.
    Hilhorst, M.
    Damoiseaux, J.
    Witzke, O.
    Tervaert, J. W. Cohen
    PRESSE MEDICALE, 2013, 42 (04): : 758 - 759
  • [48] Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation
    Ohlsson, Sophie
    Holm, Lisa
    Hansson, Christina
    Ohlsson, Susanne M.
    Gunnarsson, Lena
    Pettersson, Asa
    Skattum, Lillemor
    PLOS ONE, 2019, 14 (06):
  • [49] Increased Expression of Toll-Like Receptors by Monocytes and Natural Killer Cells in ANCA-Associated Vasculitis
    Tadema, Henko
    Abdulahad, Wayel H.
    Stegeman, Coen A.
    Kallenberg, Cees G. M.
    Heeringa, Peter
    PLOS ONE, 2011, 6 (09):
  • [50] SKEWED PERIPHERAL B AND T LYMPHOCYTES COMPARTMENTS IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS
    Dumoitier, Nicolas
    London, Jonathan
    Lofek, Sebastien
    Dion, Jeremie
    Chaigne, Benjamin
    Mocek, Julie
    Le Jeunne, Claire
    Blank, Nadine Varin
    Guillevin, Loic
    Terrier, Benjamin
    Mouthon, Luc
    RHEUMATOLOGY, 2017, 56 : 18 - 19